We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$10.4B
AUM Growth
-$723M
(-6.5%)
Cap. Flow
-$991M
Cap. Flow
% of AUM
-9.58%
Top 10 Holdings %
Top 10 Hldgs %
15.09%
Holding
1,387
New
84
Increased
397
Reduced
576
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$26.5M |
| 2 |
Marathon Petroleum
MPC
|
+$23.6M |
| 3 |
MRSH
Marsh
MRSH
|
+$20.8M |
| 4 |
Cheniere Energy
LNG
|
+$17.6M |
| 5 |
ANDV
Andeavor
ANDV
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$42.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$40.9M |
| 3 |
Apple
AAPL
|
+$35.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$33.4M |
| 5 |
GE Aerospace
GE
|
+$26.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.18% |
| 2 | Financials | 15.96% |
| 3 | Technology | 14.61% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
476
DELISTED
Kellanova
K
| $3.19M | 0.03% |
48,913
+7,438
| +18% | +$500K |
|
477
Veeco
VECO
$2.95B
| $3.19M | 0.03% |
114,357
+31,514
| +38% | +$968K |
|
478
Cencora
COR
$60.7B
| $3.18M | 0.03% |
33,612
+3,532
| +12% | +$315K |
|
479
Keurig Dr Pepper
KDP
$43B
| $3.14M | 0.03% |
34,496
+2,864
| +9% | +$268K |
|
480
Sempra
SRE
$58.6B
| $3.09M | 0.03% |
54,864
-6,586
| -11% | -$372K |
|
|
JNPR
481
DELISTED
Juniper Networks
JNPR
| $3.07M | 0.03% |
110,090
-43,892
| -29% | -$1.28M |
|
|
AEGN
482
DELISTED
Aegion Corp
AEGN
| $3.07M | 0.03% |
140,246
+2,098
| +2% | +$44.2K |
|
483
SiriusXM
SIRI
$10.4B
| $3.06M | 0.03% |
55,973
-24,809
| -31% | -$1.27M |
|
484
Apogee Enterprises
APOG
$832M
| $3.06M | 0.03% |
53,750
| – | – |
|
485
Dine Brands
DIN
$457M
| $3.04M | 0.03% |
69,037
-837
| -1% | -$41.8K |
|
486
Extra Space Storage
EXR
$31.3B
| $3.04M | 0.03% |
38,968
-49,175
| -56% | -$3.77M |
|
487
Waters Corp
WAT
$37.3B
| $3.02M | 0.03% |
16,443
| – | – |
|
488
Brown-Forman Class B
BF.B
$13.2B
| $3.01M | 0.03% |
96,813
+61,304
| +173% | +$1.92M |
|
489
CBRE Group
CBRE
$43.8B
| $3.01M | 0.03% |
82,642
-6,223
| -7% | -$216K |
|
490
Wabash National
WNC
$504M
| $3M | 0.03% |
136,568
| – | – |
|
491
Pinnacle West Capital
PNW
$12.3B
| $2.99M | 0.03% |
35,085
+95
| +0.3% | +$8.18K |
|
492
Pediatrix Medical
MD
$2.17B
| $2.97M | 0.03% |
49,166
+35,784
| +267% | +$2.12M |
|
|
WFM
493
DELISTED
Whole Foods Market Inc
WFM
| $2.96M | 0.03% |
70,239
-295,437
| -81% | -$10.8M |
|
|
BEAT
494
DELISTED
BioTelemetry, Inc.
BEAT
| $2.95M | 0.03% |
88,298
+7,019
| +9% | +$209K |
|
495
VeriSign
VRSN
$25.9B
| $2.92M | 0.03% |
31,454
-126,585
| -80% | -$11.4M |
|
496
Weibo
WB
$1.99B
| $2.9M | 0.03% |
+43,550
| New | +$2.83M |
|
|
CLGX
497
DELISTED
Corelogic, Inc.
CLGX
| $2.88M | 0.03% |
66,434
| – | – |
|
498
United Therapeutics
UTHR
$26.2B
| $2.88M | 0.03% |
22,191
+1,440
| +7% | +$180K |
|
|
MXIM
499
DELISTED
Maxim Integrated Products
MXIM
| $2.87M | 0.03% |
63,837
+7,487
| +13% | +$344K |
|
|
FL
500
DELISTED
Foot Locker
FL
| $2.86M | 0.03% |
58,069
+46,156
| +387% | +$2.99M |
|
Similar funds
HF
KBC Group's Q2 2017 Portfolio in Review
As of Q2 2017, KBC Group held 1,387 positions worth $10.4B, down 6.5% from $11.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group withdrew a net $991M in Q2 2017, closing 116 positions and reducing 576 holdings. Its most notable exit was PrivateBancorp Inc, an estimated $11.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, KBC Group opened a new position in Copa Holdings worth $5.26M.
- KBC Group's largest Q2 2017 buy was Copa Holdings: 44,950 shares worth $5.26M.
- KBC Group added most to ConocoPhillips in Q2 2017, an estimated $26.5M increase.
- KBC Group's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $42.1M.
- KBC Group fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $11.4M.
- KBC Group's ten largest holdings make up 15% of its $10.4B portfolio in Q2 2017.
- KBC Group opened 84 new positions and closed 116 in Q2 2017.
- KBC Group's portfolio value fell 6.5% quarter-over-quarter to $10.4B.
Based on KBC Group's 13F filing for Q2 2017, filed 4 Aug 2017.